{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T03:05:52Z","timestamp":1763867152318},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1097\/iio.0b013e3182011033","type":"journal-article","created":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T15:36:58Z","timestamp":1291649818000},"page":"1-16","source":"Crossref","is-referenced-by-count":11,"title":["Retinopathy of Prematurity Care"],"prefix":"10.1097","volume":"51","author":[{"given":"Lisa J.","family":"Faia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Trese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210126","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9394(42)92088-9","article-title":"Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report.","volume":"25","author":"Terry","year":"1942","journal-title":"Am J Ophthalmol"},{"key":"R3-1-20210126","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archopht.1990.01070120056029","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcomestructure and function.","volume":"108","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R4-1-20210126","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R5-1-20210126","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"Incidence and early course of retinopathy of prematurity.","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology"},{"key":"R6-1-20210126","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0161-6420(93)31665-9","article-title":"Prognostic factors in the natural course of retinopathy of prematurity.","volume":"100","author":"Schaffer","year":"1993","journal-title":"Ophthalmology"},{"key":"R7-1-20210126","first-page":"233","article-title":"Final results of the early treatment for retinopathy of prematurity randomized trial.","volume":"102","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R8-1-20210126","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1542\/peds.104.3.e26","article-title":"Current incidence of retinopathy of prematurity, 1989-97.","volume":"104","author":"Hussain","year":"1999","journal-title":"Pediatrics"},{"key":"R9-1-20210126","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.67.6.924","article-title":"Retinopathy of prematurity: an estimate of vision loss in the United States1979.","volume":"67","author":"Phelps","year":"1981","journal-title":"Pediatrics"},{"key":"R10-1-20210126","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1056\/NEJM198912143212405","article-title":"Outcomes of extremely-low-birth-weight infants between 1982 and 1988.","volume":"321","author":"Hack","year":"1989","journal-title":"N Engl J Med"},{"key":"R11-1-20210126","doi-asserted-by":"crossref","first-page":"F145","DOI":"10.1136\/fn.82.2.F145","article-title":"Severe retinopathy of prematurity and its association with different rates of survival in infants less than 1251 g birth weight.","volume":"82","author":"Vyas","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R12-1-20210126","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/bjo.85.8.933","article-title":"Reduced incidence of retinopathy of prematurity.","volume":"85","author":"Rowlands","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R13-1-20210126","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.80.5.420","article-title":"Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.","volume":"80","author":"Pennefather","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"R14-1-20210126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1091-8531(99)70094-7","article-title":"The decreasing incidence and severity of retinopathy of prematurity.","volume":"3","author":"Bullard","year":"1999","journal-title":"J AAPOS"},{"key":"R15-1-20210126","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/S0021-9258(19)41631-1","article-title":"Purification of a basic fibroblast growth factor from bovine pituitary.","volume":"250","author":"Gospodarowicz","year":"1975","journal-title":"J Biol Chem"},{"key":"R16-1-20210126","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.2422759","article-title":"Transforming growth factor alpha: a more potent angiogenic mediator than epidermal growth factor.","volume":"232","author":"Schreiber","year":"1986","journal-title":"Science"},{"key":"R17-1-20210126","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1073\/pnas.84.15.5277","article-title":"Tumor necrosis factor alpha, a potent inhibitor of endothelial cell growth in vitro is angiogenic in vivo.","volume":"84","author":"Frater-Schroder","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-1-20210126","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.","volume":"358","author":"Shweki","year":"1992","journal-title":"Nature"},{"key":"R19-1-20210126","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"R20-1-20210126","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factorvascular permeability factor expression in a mouse model of retinal neovascularization.","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-1-20210126","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R22-1-20210126","first-page":"1025","article-title":"Vascular endothelial growth factor acts as a survival factor for newly reformed retinal vessels and implications for retinopathy of prematurity.","volume":"10","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"R23-1-20210126","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/archopht.1996.01100140179011","article-title":"Localization of vascular endothelial growth factor in human retina and choroid.","volume":"114","author":"Lutty","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R25-1-20210126","first-page":"385","article-title":"Studies on retinopathy of prematurity: III. Cryocautery for retinopathy of prematurity.","volume":"26","author":"Yamashita","year":"1972","journal-title":"Jpn J Ophthalmol"},{"key":"R27-1-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/oxfordjournals.bmb.a070758","article-title":"Retinal angiogenesis in the human embryo.","volume":"26","author":"Ashton","year":"1970","journal-title":"Br Med Bull"},{"key":"R28-1-20210126","first-page":"471","article-title":"An international classification of retinopathy of prematurity.","volume":"106","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"R29-1-20210126","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archopht.1987.01060070042025","article-title":"An international classification of retinopathy of prematurity. II. The classification of retinal detachment.","volume":"105","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R30-1-20210126","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results.","volume":"106","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R31-1-20210126","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archopht.1993.01090030057039","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: 3 year outcomestructure and function.","volume":"111","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R32-1-20210126","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.1994.01090190051021","article-title":"The natural ocular outcome of premature birth and reinopathy. Status at 1 year.","volume":"112","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R33-1-20210126","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/IAE.0b013e31815e987f","article-title":"The photographic screening for retinopathy of prematurity study: primary outcomes.","volume":"28","year":"2008","journal-title":"Retina"},{"key":"R35-1-20210126","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0008-4182(00)80073-3","article-title":"Commentary on guidelines for screening for retinopathy of prematurity.","volume":"35","author":"Ells","year":"2000","journal-title":"Can J Ophthalmol"},{"key":"R36-1-20210126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1091-8531(97)90023-9","article-title":"Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group Outcome-based management of retinopathy of prematurity.","volume":"1","author":"Hardy","year":"1997","journal-title":"J AAPOS"},{"key":"R37-1-20210126","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaapos.2008.10.014","article-title":"Cost-utility analysis of screening and laser treatment of retinopathy of prematurity.","volume":"13","author":"Dunbar","year":"2009","journal-title":"J AAPOS"},{"key":"R39-1-20210126","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archophthalmol.2009.97","article-title":"Retinopathy of prematurity malpractice claims: the ophthalmic mutual insurance company experience.","volume":"127","author":"Day","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R40-1-20210126","first-page":"461","article-title":"Malpractice and the quality of care in retinopathy of prematurity (an American Ophthalmological Society thesis).","volume":"105","author":"Reynolds","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R41-1-20210126","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0161-6420(03)00831-5","article-title":"Telemedicine approach to screening for severe retinopathy of prematurity-: a pilot study.","volume":"110","author":"Ells","year":"2003","journal-title":"Ophthalmology"},{"key":"R43-1-20210126","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(89)32895-8","article-title":"The validity and reliability of photographic documentation of proliferative vitreoretinopathy.","volume":"96","author":"Azen","year":"1989","journal-title":"Ophthalmology"},{"key":"R44-1-20210126","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2337\/diacare.16.6.889","article-title":"Screening for diabetic retinopathy. The wide-angle retinal camera.","volume":"16","author":"Pugh","year":"1993","journal-title":"Diabetes Care"},{"key":"R45-1-20210126","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited.","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R46-1-20210126","first-page":"54","article-title":"Initial sign and clinical course of the most severe form of acute proliferative retrolental fibroplasias (type 1) (in Japanese).","volume":"80","author":"Morizane","year":"1976","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"R47-1-20210126","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICU.0b013e3281107fd3","article-title":"Current understanding and management of retinopathy of prematurity.","volume":"18","author":"Quiram","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"R48-1-20210126","first-page":"1065","article-title":"Viterous VEGF levels in infants with stage 4 or 5 ROP.","volume":"15","author":"Sonmez","year":"2008","journal-title":"Retina"},{"key":"R49-1-20210126","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archopht.119.8.1110","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years.","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R50-1-20210126","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archopht.119.8.1120","article-title":"Effect of retinal ablative therapy for threshold retinopathy of prematurity: results of Goldmann perimetry at the age of 10 years.","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R51-1-20210126","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archopht.119.8.1129","article-title":"Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity.","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R52-1-20210126","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0161-6420(99)00042-1","article-title":"A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity.","volume":"107","author":"Banach","year":"2000","journal-title":"Ophthalmology"},{"key":"R53-1-20210126","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9394(99)00475-4","article-title":"Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity.","volume":"129","author":"Lambert","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R54-1-20210126","first-page":"615","article-title":"Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity.","volume":"119","author":"Kaiser","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R55-1-20210126","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0002-9394(01)00956-4","article-title":"Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome.","volume":"132","author":"Shalev","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R56-1-20210126","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bjo.82.11.1254","article-title":"Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.","volume":"82","author":"Pearce","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"R57-1-20210126","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/bjo.82.11.1246","article-title":"Longer term visual outcome of eyes with retinopathy treated with cryotherapy or diode laser.","volume":"82","author":"OKeefe","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"R58-1-20210126","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0161-6420(01)00695-9","article-title":"Outcomes after laser therapy for threshold retinopathy of prematurity.","volume":"108","author":"Foroozan","year":"2001","journal-title":"Ophthalmology"},{"key":"R59-1-20210126","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(98)99029-7","article-title":"A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity.","volume":"105","author":"Connolly","year":"1998","journal-title":"Ophthalmology"},{"key":"R60-1-20210126","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archopht.118.3.365","article-title":"Diode laser ablation for threshold retinopathy of prematurity. Short-term structural outcome.","volume":"118","author":"DeJonge","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R61-1-20210126","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9394(14)71402-3","article-title":"Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity.","volume":"116","author":"Capone","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R62-1-20210126","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/bjo.84.12.1383","article-title":"Diode laser treatment of posterior retinopathy of prematurity.","volume":"84","author":"Axer-Siegel","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R63-1-20210126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archopht.1990.01070040047029","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome.","volume":"108","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R64-1-20210126","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.1993.01090080046017","article-title":"Prediction of visual function in eyes with mild to moderate posterior pole residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.","volume":"111","author":"Reynolds","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R65-1-20210126","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archopht.1996.01100140287005","article-title":"Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome.","volume":"114","author":"Gilbert","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R66-1-20210126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0161-6420(94)31362-5","article-title":"Scleral buckling for retinopathy of prematurity.","volume":"101","author":"Trese","year":"1994","journal-title":"Ophthalmology"},{"key":"R67-1-20210126","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0161-6420(90)32506-X","article-title":"Scleral buckling in stages 4B and 5 retinopathy of prematurity.","volume":"97","author":"Greven","year":"1990","journal-title":"Ophthalmology"},{"key":"R68-1-20210126","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(98)96024-9","article-title":"Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity.","volume":"105","author":"Trese","year":"1998","journal-title":"Ophthalmology"},{"key":"R69-1-20210126","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0161-6420(01)00809-0","article-title":"Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments.","volume":"108","author":"Capone","year":"2001","journal-title":"Ophthalmology"},{"key":"R70-1-20210126","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ophtha.2004.05.030","article-title":"Lens-sparing vitrectomy for stage 4 retinopathy of prematurity.","volume":"111","author":"Hubbard","year":"2004","journal-title":"Ophthalmology"},{"key":"R71-1-20210126","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2004.06.021","article-title":"Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity.","volume":"111","author":"Prenner","year":"2004","journal-title":"Ophthalmology"},{"key":"R72-1-20210126","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archopht.116.11.1446","article-title":"Refractive changes associated with scleral buckling and division in retinopathy of prematurity.","volume":"116","author":"Chow","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R73-1-20210126","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00006982-200410000-00011","article-title":"Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity.","volume":"24","author":"Hartnett","year":"2004","journal-title":"Retina"},{"key":"R74-1-20210126","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/IAE.0b013e3181ec80dc","article-title":"Ab interno incision for pediatric vitreoretinal surgery.","volume":"30","author":"Ho","year":"2010","journal-title":"Retina"},{"key":"R75-1-20210126","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1073\/pnas.93.10.4851","article-title":"Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.","volume":"93","author":"Robinson","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R76-1-20210126","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R77-1-20210126","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.031252398","article-title":"Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor.","volume":"98","author":"Stellmach","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R78-1-20210126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOP.0b013e32832925f9","article-title":"Antivascular endothelial growth factor for retinopathy of prematurity.","volume":"21","author":"Mintz-Hittner","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"R80-1-20210126","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"R81-1-20210126","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaapos.2009.10.011","article-title":"Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity.","volume":"14","author":"Law","year":"2010","journal-title":"J AAPOS"},{"key":"R82-1-20210126","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.","volume":"245","author":"Chung","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R83-1-20210126","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bjo.85.8.991","article-title":"Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity.","volume":"85","author":"Chowers","year":"2001","journal-title":"Br J Ophthalmol"}],"container-title":["International Ophthalmology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IIO.0b013e3182011033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T11:24:58Z","timestamp":1685877898000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004397-201105110-00001"}},"subtitle":["Screening to Vitrectomy"],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iio.0b013e3182011033","relation":{},"ISSN":["0020-8167"],"issn-type":[{"value":"0020-8167","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}